- Home
- GTX vs SRRK Comparison
GTX vs SRRK Comparison
Compare GTX & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTX
- SRRK
- Stock Information
- Founded
- GTX 2018
- SRRK 2012
- Country
- GTX Switzerland
- SRRK United States
- Employees
- GTX N/A
- SRRK N/A
- Industry
- GTX Auto Parts:O.E.M.
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GTX Consumer Discretionary
- SRRK Health Care
- Exchange
- GTX Nasdaq
- SRRK Nasdaq
- Market Cap
- GTX 2.7B
- SRRK 3.0B
- IPO Year
- GTX N/A
- SRRK 2018
- Fundamental
- Price
- GTX $16.78
- SRRK $37.38
- Analyst Decision
- GTX Strong Buy
- SRRK Strong Buy
- Analyst Count
- GTX 3
- SRRK 9
- Target Price
- GTX $16.33
- SRRK $47.88
- AVG Volume (30 Days)
- GTX 4.3M
- SRRK 2.1M
- Earning Date
- GTX 10-23-2025
- SRRK 11-14-2025
- Dividend Yield
- GTX 1.90%
- SRRK N/A
- EPS Growth
- GTX 55.30
- SRRK N/A
- EPS
- GTX 1.57
- SRRK N/A
- Revenue
- GTX $3,537,000,000.00
- SRRK N/A
- Revenue This Year
- GTX $3.51
- SRRK N/A
- Revenue Next Year
- GTX $3.17
- SRRK $1,987.65
- P/E Ratio
- GTX $10.71
- SRRK N/A
- Revenue Growth
- GTX N/A
- SRRK N/A
- 52 Week Low
- GTX $7.02
- SRRK $22.71
- 52 Week High
- GTX $17.91
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- GTX 61.98
- SRRK 69.21
- Support Level
- GTX $17.13
- SRRK $29.35
- Resistance Level
- GTX $17.75
- SRRK $31.46
- Average True Range (ATR)
- GTX 0.45
- SRRK 1.69
- MACD
- GTX -0.09
- SRRK 0.82
- Stochastic Oscillator
- GTX 11.86
- SRRK 83.27
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.